
	Where results make sense

Topic: Brook Byers

Related Topics

Tom Byers

Stanford Business School

Business school

Andy Bechtolsheim

MBA

Steve Ballmer

Entrepreneurship

In the News (Thu 24 Dec 09)

Northern Trust

Marvin Harrison

Peter Chernin

Gary Locke

Match Play

Penelope Cruz

Mickey Rourke

AR Rahman

Danny Boyle

Hugh Jackman

	Educators Corner: Entrepreneurship Education Resources
		Brook Byers has been a venture capital investor since 1972.
		Brook was the founding President and then Chairman of four biotechnology companies which were incubated in KPCB's offices and went on to become public companies with an aggregate market value over $8 Billion.
		Brook was President and a Director of the Western Association of Venture Capitalists and is a contributing author to the book "Guide to Venture Capital".
	edcorner.stanford.edu /authorMaterialInfo.html?author=167 (359 words)

	VC firm invests against disease / Avian flu prompts Kleiner Perkins to open new fund
		Partner Brook Byers said the Menlo Park firm formed its Pandemic and Bio Defense Fund after concluding that emerging diseases present a significant worldwide health threat and create an urgent need for new solutions.
		Byers said the potential for a global pandemic of bird flu that could kill millions of people has alerted world governments to the need for preventive measures.
		Byers said he is encouraged by government efforts to improve financial incentives that encourage private companies to develop new medicines and medical tools.
	www.sfgate.com /cgi-bin/article.cgi?file=/c/a/2006/02/16/BUG4PH94901.DTL&type=printable (527 words)

	SiliconBeat: S.F. gets stem cell agency
		Both Newsom and his lead negotiator on the issue, Jessie Blout, mentioned the support offered by Kleiner Perkins' Brook Byers at the final pitch in Fresno Friday.
		Byers, Newsom continued, explained how he not only invested in biotech companies, "but ones coming up to the Bay Area and San Francisco, and wouldn't be doing that unless the companies were here because the region has the best talent."
		Byers' Kliener Perkins provided the original financing for Genentech, one of the first biotech companies in the world.
	www.siliconbeat.com /entries/2005/05/06/sf_gets_stem_cell_agency.html (400 words)

	UCSF Today - Chancellor to Award UCSF Medals to Four Leaders on May 3
		Brook Byers has played a vital leadership role in UCSF’s development efforts that contributed to the birth of the 43-acre life sciences campus at Mission Bay.
		Active with the UCSF Foundation since 1987, Byers served as co-chair of the Campaign for UCSF from 1998 to 2005, which raised $1.4 billion.
		A venture capital investor since 1972, Byers has been closely involved with more than 60 new technology-based ventures that have pioneered the fields of monoclonal antibodies, protein therapeutics, DNA sequencing and other fields, producing more than 100 products approved by the Food and Drug Administration to improve patient care.
	pub.ucsf.edu /today/cache/news/200704263.html (1802 words)

	Byers Carolers from Byers Choice at Fiddlesticks
		Joyce Byers have seen their hobby grow into a family
		Byers Carolers images and logos were scanned from Byers' Choice Ltd.
		promotional materials, and are the property of Byers' Choice Ltd.
	www.fiddlesticksdallas.com /byers_carolers_from_byers_choice.htm (62 words)

	XDx Inc. - Directors
		Brook Byers (Chairman), Kleiner Perkins Caufield & Byers
		Brook Byers has been a venture capital investor since 1972 and in 1984 he formed the first life science practice group in the venture capital profession to help Kleiner Perkins Caufield and Byers (KPCB) become a premier venture firm in the medical, health care and biotechnology fields.
		Brook is currently a board member of seven companies including XDx (Chairman).
	www.xdx.com /corp/directors.htm (1154 words)

	KPCB - Team
		Brook Byers has been a venture capital investor since 1972.
		Brook was President and a Director of the Western Association of Venture Capitalists and is a contributing author of the book “Guide to Venture Capital”.
		Raised in Atlanta, Georgia, Brook graduated in Electrical Engineering from Georgia Tech and received an MBA from Stanford.
	www.kpcb.com /team/index.php?Brook (0 words)

	Pratt e-Press@Duke University
		Brook Byers, a venture capitalist and Pratt parent, kicked off the 2006 Parents' Weekend seminar and barbeque by soothing parents’ fears that their child wouldn't get a good job.
		Byers forecasts growth in voice and face recognition technology, and significant improvements in telecommunications and medical imaging as photonics and semiconductors move to their next generation.
		Byers said it was a combination of experiences that has prepared him for his next step: graduate school in biomedical engineering.
	www.pratt.duke.edu /pratt_press/web.php?sid=373&iid=42 (2164 words)

	Kleiner Perkins Caufield & Byers Mercury News interview (Site not responding. Last check: )
		Kleiner Perkins Caufield and Byers Mercury News interview
		Matt Marshall of the San Jose Mercury News recently visited venture capital firm Kleiner Perkins Caufield and Byers to interview partners John Doerr, Brook Byers and Ray Lane.
		Brook Byers: Network was a thing of the 1990s.
	www.niallkennedy.com /blog/archives/2004/11/kleiner_perkins.html (180 words)

	FuturePundit: Science Policy Archives (Site not responding. Last check: )
		But what is most important to note is that when effective treatments were found for them the costs of preventing and treating them became a small fraction of the costs that those diseases previously inflicted on their victims, families of victims, and the rest of society.
		Byers says there are multiple groups in the United States and England that are working on nanoscale-level devices for very rapidly and cheaply sequence whole human genomes.
		Byers expects this problem to be solved in a few years.
	www.futurepundit.com /archives/cat_science_policy.html (5831 words)

	San Diego Metropolitan - Biotech in San Diego - April 1999
		Byers was known for religiously studying matters technological, and Greene wanted to pick his brain.
		What he didn’t know was that Byers was already looking into funding a company in the exact same field.
		Byers introduced Greene to firm partner Tom Perkins on a boat at Balboa Island in Orange County "and the two of us just bonded.
	www.sandiegometro.com /1999/apr/biotech.html (2790 words)

	SiliconBeat: Q&A with Kleiner Perkins Caufield & Byers
		John Doerr, Brook Byers and Ray Lane are partners at Kleiner Perkins Caufield & Byers, one of Silicon Valley's most prestigious venture capital firms.
		Byers: Right after this meeting I'm going up to UCSF and visiting labs, prowling labs, that's the best part of this job.
		Byers (pictured at left): Matt, Kleiner Perkins is basically a service business.
	www.siliconbeat.com /entries/2004/11/13/qa_with_kleiner_perkins_caufield_byers.html (1906 words)

	VC Goes PC
		Byers: Over a three-year period we'll look to invest the fund in roughly 40 companies across a set of industry sectors that include mobile computing, Web-enabled software, biotech, medical devices, semiconductors, and then an area that we are highlighting this time that we call green tech, which is new energy sources and things like that.
		Byers: We have been investing in green-tech-type companies for about five years, but like a lot of companies in tech today, they wanted to remain quiet, or stealth, because they're in their R&D phase.
		Byers: As we were doing our strategic planning last year, it became obvious to us that worldwide infectious diseases and the innovation toward stopping them have huge gaps in four basic areas.
	www.businessweek.com /investor/content/feb2006/pi20060227_902533.htm (2016 words)

	Novavax Offering Bolsters Avian Vaccine Confidence - Word on the Street (Site not responding. Last check: )
		Perkins Caufield and Byers, based in Menlo Park, California, has agreed to acquire $12.5 million or 62.5% of this offering.
		Brook Byers, Managing Partner of Kleiner Perkins Caufield and Byers, said: "Our investment in Novavax is aligned with our intent to support global efforts to address the public health threat posed by the current H5N1 strain or other strains of avian influenza virus.
		Investors are reacting positively to this funding news, seeing the endorsement by investors as a sign of confidence in Novavax's influenza vaccine.
	www.antandsons.com /2006/02/novavax-offering-bolsters-avian.html (298 words)

	Tom Byers, Kavita Ramdas, Paul Yock, John Hennessy, Brook Byers, Jeff Ko...
		Tom Byers, Kavita Ramdas, Paul Yock, John Hennessy, Brook Byers, Jeff Ko...
		Tom Byers, Kavita Ramdas, Paul Yock, John Hennessy, Brook Byers, Jeff Koseff, Chip Blacker, KR Sridhar (eWeek Panel Discussion)
		They tackle world issues from a global and technical perspective beyond the usual bureaucratic approach with a special focus on developing nations.
	odeo.com /audio/9768763/view (109 words)

	10th Anniversary C21 BioVentures \| May 20-22, 2008 \| Napa, California
		KPCB has invested in and helped build over 110 Life Sciences companies which are developing hundreds of products to treat major underserved medical needs representing huge markets in the nearly two trillion dollar healthcare sector.
		Brook was the founding President and then Chairman of four biotechnology companies which were incubated in KPCB's offices and went on to become public companies with an aggregate market value over $8 Billion.
		Brook was President and a Director of the Western Association of Venture Capitalists.
	www.techvision.com /c21/participants/advisory/detail.php?id=16 (0 words)

	News: OptiMedica Raises $13.8 Million in Financing; Kleiner Perkins Caufield & Byers, Alloy Ventures Invest in Growth. ...
		Brook Byers, Partner with Kleiner Perkins Caufield & Byers and Chairman of the Board of OptiMedica, commented "There is tremendous opportunity in ophthalmology driven by changes in demography and by diabetes prevalence occurring in epidemic proportions.
		OptiMedica holds the exclusive license to the PASCAL(R) (PAttern SCAn Laser) method of photocoagulation and its associated technologies, which are FDA approved to treat a variety of retinal conditions.
		OptiMedica was founded 2004 in Santa Clara, Calif. and is funded by Kleiner, Perkins, Caufield & Byers and Alloy Ventures.
	www.genengnews.com /news/bnitem.aspx?name=795919 (420 words)

	Clean Edge - The Clean-Tech Market Authority - News
		Kleiner Perkins Caufield & Byers (KPCB), one of the leading Silicon Valley venture firms, today KPCB is announcing a new $100 million initiative in "green technologies."
		KPCB XII partners include KPCB XI partners Brook Byers, John Denniston, John Doerr, Juliet Flint, Joe Lacob, Ray Lane, Aileen Lee, Matt Murphy, Ajit Nazre, Ph.D, Ted Schlein, Risa Stack, Ph.D, and Trae Vassallo.
		New partners added since the KPCB XI fund closed include Bill Joy, Randy Komisar, Ying Lee, Dana Mead, Jr., Ellen Pao, and Beth Seidenberg, M.D. "The pace of innovation is accelerating, as three billion consumers enter the global marketplace," said Brook Byers.
	www.cleanedge.com /story.php?nID=3972 (373 words)

	Technology Review: Making Waves
		Perkins, a founding partner in the venture capital firm Kleiner Perkins Caufield and Byers (KPCB), has made a career of envisioning new ideas.
		"His influence as a Silicon Valley pioneer is huge," says KPCB partner Brook Byers.
		When he formed Kleiner Perkins in 1972, it was one of the few venture capital firms in the world." An astute investor, Perkins helped ignite the boom in the high-tech and biotech industries -- and then pitched in to help manage the companies he funded.
	www.technologyreview.com /read_article.aspx?id=17115 (516 words)

	Invention 101
		Byers works closely with university researchers in commercializing cutting edge technology in the life sciences.
		Also on the panel was Rob Valli, director of The Kauffman Foundation, an organization dedicated to enhancing university entrepreneurship, and Donna Cookmeyer, associate director of Duke’s Office of Licensing and Ventures.
		Byers also pointed audience members to The World is Flat: A Brief History of the Twenty-first Century by Thomas Friedman, a book about globalization that he considers required reading.
	www.dukenews.duke.edu /2006/02/invention.html (448 words)

	Venture capitalists love pharmaceuticals - Apr. 28, 1998
		SAN FRANCISCO (The Red Herring) - Brook Byers of Kleiner Perkins Caufield and Byers traces the beginnings of venture capital investment in biotechnology to the founding of Genentech in 1976.
		Byers argues that skeptics of the biotech startup market often fail to consider the increasingly prominent role that large pharmaceutical companies are playing in forming alliances with startups.
		Byers estimates that the chemical library of Merck, a century-old company, comprises only 500,000 compounds.
	money.cnn.com /1998/04/28/redherring/redherring_betterliving (1517 words)

	About Genomic Health - The Team
		Byers is a general partner of Kleiner Perkins Caufield and Byers, a venture capital firm which he joined in 1977.
		Byers currently serves as a director of Five Prime Therapeutics, XDx, Cardio DX, OptiMedica and a number of privately held technology, healthcare and biotechnology companies.
		Byers holds a BS in electrical engineering from the Georgia Institute of Technology and an MBA from the Stanford Graduate School of Business.
	www.genomichealth.com /about/team.aspx (1503 words)

Try your search on: Qwika (all wikis)